4:54 PM
 | 
Apr 26, 2011
 |  BC Extra  |  Company News

Karo Bio, Alkem in deal for eprotirome

Karo Bio AB (SSE:KARO) granted Alkem Laboratories Ltd. (Mumbai, India) exclusive rights to commercialize metabolic candidate eprotirome in India and other Asia-Pacific and African markets. Alkem plans to conduct...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >